Literature DB >> 10727733

In vivo evidences of early neurosteroid synthesis in the developing rat central nervous system and placenta.

P E Pomata1, A A Colman-Lerner, J L Barañao, M L Fiszman.   

Abstract

The aim of the present study was to determine the developmental pattern of progesterone metabolism in rat brain and spinal cord from embryonic day 13 (E13) to the perinatal period. A marked decrease in the 5alpha-reduction of progesterone in brain cortex was observed between E13 and postnatal day 5 (P5). Isopregnanolone was the predominant isomer in E13 in both cortex and spinal cord and its synthesis diminished gradually, while the concentration of allopregnanolone did not change significantly during development. The placental tissue was able to synthesize the 3alpha and 3beta isomers in E13, E16 and E19 embryos with allopregnanolone being the major metabolite in all the samples. We conclude that embryonic central nervous system tissues are able to synthesize neurosteroids at least from stage E13 and that they are developmentally regulated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10727733     DOI: 10.1016/s0165-3806(99)00181-9

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  10 in total

1.  The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression.

Authors:  Jun Ming Wang; Patrick B Johnston; Bret Gene Ball; Roberta Diaz Brinton
Journal:  J Neurosci       Date:  2005-05-11       Impact factor: 6.167

2.  The pregnancy hormones human chorionic gonadotropin and progesterone induce human embryonic stem cell proliferation and differentiation into neuroectodermal rosettes.

Authors:  Miguel J Gallego; Prashob Porayette; Maria M Kaltcheva; Richard L Bowen; Sivan Vadakkadath Meethal; Craig S Atwood
Journal:  Stem Cell Res Ther       Date:  2010-09-13       Impact factor: 6.832

3.  Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2.

Authors:  Lifei Liu; Junming Wang; Liqin Zhao; Jon Nilsen; Kelsey McClure; Karren Wong; Roberta Diaz Brinton
Journal:  Endocrinology       Date:  2009-04-09       Impact factor: 4.736

4.  Progesterone reduces hyperactivity of female and male dopamine transporter knockout mice.

Authors:  Cheryl A Frye; Ichiro Sora
Journal:  Behav Brain Res       Date:  2010-01-20       Impact factor: 3.332

Review 5.  Endogenous and synthetic neurosteroids in treatment of Niemann-Pick Type C disease.

Authors:  Synthia H Mellon; Wenhui Gong; Marcus D Schonemann
Journal:  Brain Res Rev       Date:  2007-06-12

6.  Early postnatal allopregnanolone levels alteration and adult behavioral disruption in rats: Implication for drug abuse.

Authors:  Iris Bartolomé; Anna Llidó; Sònia Darbra; Marc Pallarès
Journal:  Neurobiol Stress       Date:  2019-12-27

7.  Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease.

Authors:  Samuel O Adeosun; Xu Hou; Yun Jiao; Baoying Zheng; Sherry Henry; Rosanne Hill; Zhi He; Amar Pani; Patrick Kyle; Xiaoming Ou; Thomas Mosley; Jerry M Farley; Craig Stockmeier; Ian Paul; Steven Bigler; Roberta Diaz Brinton; Richard Smeyne; Jun Ming Wang
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

Review 8.  Regeneration in a degenerating brain: potential of allopregnanolone as a neuroregenerative agent.

Authors:  Jun Ming Wang; Ronald W Irwin; Lifei Liu; Shuhua Chen; Roberta Diaz Brinton
Journal:  Curr Alzheimer Res       Date:  2007-12       Impact factor: 3.498

Review 9.  Allopregnanolone and neurogenesis in the nigrostriatal tract.

Authors:  Jun Ming Wang
Journal:  Front Cell Neurosci       Date:  2014-08-12       Impact factor: 5.505

10.  Botanical Drug Puerarin Promotes Neuronal Survival and Neurite Outgrowth against MPTP/MPP+-Induced Toxicity via Progesterone Receptor Signaling.

Authors:  Yingke Zhao; Jia Zhao; Xiuying Zhang; Yuanyuan Cheng; Dan Luo; Simon Ming-Yuen Lee; Lixing Lao; Jianhui Rong
Journal:  Oxid Med Cell Longev       Date:  2020-10-17       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.